Fusmobile
Founded 2014 · 22 employees on LinkedIn · 2 known investors
FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.
Investors · 2
Frequently asked questions
- What does Fusmobile do?
- FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.
- Who are Fusmobile's investors?
- Fusmobile's investors include Atlanta Technology Angels, OrbiMed.